FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to drain ovarian Cancer's fluid trap
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) works better than bevacizumab alone for recurrent ovarian, fallopian tube, or peritoneal cancer that causes fluid buildup. About 60 adults w…
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:40 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer patients?
Disease control Recruiting nowThis study looks at the safety of giving heated chemotherapy directly into the belly during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 people will receive either chemotherapy before surgery or heated chemotherapy during surgery. The goal is to se…
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:36 UTC
-
Shorter treatment may be just as effective for ovarian cancer patients
Disease control Recruiting nowThis study looks at whether taking the drug olaparib for one year is as good as taking it for two years to keep ovarian cancer from coming back. It includes people with advanced ovarian cancer who have certain gene changes (BRCA or HRD). The goal is to find the best treatment len…
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC